STRM Earnings Prediction
The chart below shows how STRM performed 10 days before and after its earnings report, based on data from the past quarters. Typically, STRM sees a -6.61% change in stock price 10 days leading up to the earnings, and a -16.80% change 10 days following the report. On the earnings day itself, the stock moves by +9.62%. This data can give you a slight idea of what to expect for the next quarter's release.
STRM Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
6.13M
-1.35%
6.29%
Gross Margin
53.07%
24.64%
8.46%
Operating Margin
-35.40%
-30.36%
-21.11%
Net Margin
-194.21%
284.80%
345.54%
EPS
-3.15
-218.18%
370.15%
No Data Available
STRM Earnings Analysis
Streamline Health Solutions, Inc. Corporation (STRM.O) Earnings Conference Call
Positive
New Contract Acquisitions: Successfully closed new contracts with an aggregate SaaS ACV of $700,000 during the third quarter.
Quarterly Revenue Comparison: Total revenue for the third quarter of fiscal 2024 was $4.4 million, compared to $6.1 million during the same period in fiscal 2023, reflecting growth in SaaS revenue solutions.
SaaS Revenue Comparison: SaaS revenue for the third quarter of fiscal 2024 totaled $2.9 million, 66% of total revenue, compared to $3.9 million, 64% of total revenue during the third quarter of fiscal 2023.
SaaS ACV and EBITDA Expectations: Booked SaaS ACV as of October 31, 2024, totaled $14.1 million, with expectations to generate consistent positive adjusted EBITDA above $15.5 million SaaS ARR run rate.
Revenue and Profitability Outlook: We anticipate significant revenue growth in fiscal 2025 and the achievement of persistent adjusted EBITDA profitability.
Negative
Quarterly Revenue Comparison: Total revenue for the third quarter of fiscal 2024 was $4.4 million compared to $6.1 million during the third quarter of fiscal 2023.
Revenue Decline Analysis: For the nine months ended October 31, 2024, revenue totaled $13.2 million compared to $17.2 million during the same period in fiscal 2023.
Net Loss Comparison Q3: Net loss for the third quarter of fiscal 2024 totaled $2.5 million compared to a net loss of $11.9 million during the third quarter of fiscal 2023.
Net Loss Comparison: Net loss during the nine months ended October 31, 2024, totaled $8 million compared to a net loss of $17.3 million during the 2023 period.
Adjusted EBITDA Loss: Adjusted EBITDA for the third quarter of fiscal 2024 was a loss of $0.3 million compared to a gain of $0.4 million during the third quarter of fiscal 2023.
STRM FAQs
How does STRM typically perform around its earnings report dates?
Is Streamline Health Solutions, Inc. (STRM) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
STRM Earning Call Sentiment
Streamline Health Solutions, Inc. (STRM) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
STRM.O
5.13%Positive
The earnings call revealed a decline in revenue and SaaS growth due to client non-renewals, with a net loss of $2.5 million. Despite optimistic guidance for fiscal 2025, current financial stability is concerning, with high debt and low cash reserves. The Q&A highlighted competitive pressures and unclear management responses, further raising uncertainties. The lack of shareholder return initiatives and a sequential revenue decline in Q3 contribute to a negative sentiment, likely leading to a stock price decrease in the short term.
